Anti-Spike RBD Antibody (Casirivimab)
Catalog No.
F1024
Anti-Spike RBD Antibody (Casirivimab)
Featured Products
Casirivimab (REGN10933) is a human monoclonal antibody that targets SARS-CoV-2, the virus that causes COVID-19. Casirivimab lacks efficacy against COVID-19 variants. Casirivimab can be used in combination with Imdevimab to effectively reduce viral load and improve symptoms.
145.24 kDa
Dry ice
2415933-42-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
REGN-10933, REGN10933
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Spike RBD
Please avoid freeze-thaw cycles.